Goods & Services
Class 5:
Pharmaceutical preparations for the treatment of erythropoietic porphyria (EPP), X-linked protoporphyria (XLPP), genetic diseases and disorders, dermatological diseases and disorders, hematological diseases and disorders, liver diseases and disorders, and photosensitivity.
Class 10:
Medical tools being devices for diagnosing erythropoietic protoporphyria; medical tools being devices for treating and diagnosing sun exposure.
Class 42:
Research and development of pharmaceuticals and biologics for the treatment of immunologic disorders, hematologic disorders, anemia disorders, oncologic disorders and renal disorders; none of the foregoing offered in connection with treatment of diseases or disorders relating to spinal discs; scientific research and development in the field of sun exposure and related disease risk; research and development of pharmaceuticals, biologic preparations and medicines in the field of sun exposure and related disease risk; medical research and development in the field of sun exposure and related disease risk; conducting surveys and questionnaires being surveys to detect sun exposure and related disease risk.
